- Watson Pharma held 3q2011 earnings conference call 11/1/2011 - click here for transcript.
- With regards to BiotechDueDiligence stocks, WPI licensed Anturol from AIS and is to market Amphstar's generic Lovenox in competition with MNTA, pending the legal case.
- See excerpts from the call and my notes below: